Wee Joo Chng

Title: Innovations of Wee Joo Chng: A Pioneer in Antibody Development

Introduction

Wee Joo Chng is a notable inventor based in Singapore, recognized for his contributions to the field of biotechnology. His work primarily focuses on the development of innovative antibodies that have significant implications in cancer detection and treatment. With a single patent to his name, he has made a mark in the scientific community.

Latest Patents

Wee Joo Chng holds a patent for an anti-oligosaccharide antibody. This invention is an antigen-binding protein that specifically binds to a Lewis X type glycan on SLAMF7. The patent details a heavy chain variable domain with specific amino acid sequences for VHCDR1, VHCDR2, and VHCDR3. Additionally, it includes a light chain variable domain with defined sequences for VLCDR1, VLCDR2, and VLCDR3. The methods outlined in the patent are aimed at detecting or treating cancer, and it also describes a kit that comprises the antibody.

Career Highlights

Throughout his career, Wee Joo Chng has worked with esteemed organizations such as the Agency for Science, Technology and Research and the National University of Singapore. His experience in these institutions has contributed to his expertise in antibody research and development.

Collaborations

Wee Joo Chng has collaborated with notable colleagues, including Chong Kok Teo and Andre Boon Hwa Choo. These partnerships have likely enhanced his research efforts and broadened the impact of his work.

Conclusion

Wee Joo Chng's innovative contributions to antibody development highlight his role as a significant figure in biotechnology. His patent for an anti-oligosaccharide antibody showcases his commitment to advancing cancer detection and treatment methods.